● Recruiting

A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications

Condition: Renal Allograft Recipients · Sponsor: Bristol-Myers Squibb

PhasePhase 3

Planned participants102

Who can joinAll sexes, 12 Years to 17 Years

Healthy volunteersNo

About this study

The purpose of this study is to evaluate the benefits and risks of conversion of existing adolescent kidney allograft recipients aged 12 to less than 18 years of age to a belatacept-based immunosuppressive regimen as compared to continuation of a calcineurin inhibitor-based regimen and their adherence to immunosuppressive medications.

This description comes directly from the study's public registry record.

Talk to the study team

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com

First line of the email MUST contain NCT # and Site #.

Always discuss trial participation with your own doctor first.

Locations (38)

Local Institution - 0042	Birmingham, Alabama, United States	Withdrawn
Local Institution - 0041	Los Angeles, California, United States	Withdrawn
Local Institution - 0014	Washington D.C., District of Columbia, United States	Withdrawn
Local Institution - 0022	Hollywood, Florida, United States	Withdrawn
Local Institution - 0045	Miami, Florida, United States	Withdrawn
Local Institution - 0049	Atlanta, Georgia, United States	Withdrawn
Local Institution - 0033	Chicago, Illinois, United States	Withdrawn
Local Institution - 0017	Baltimore, Maryland, United States	Withdrawn
Local Institution - 0044	Boston, Massachusetts, United States	Withdrawn
Local Institution - 0043	St Louis, Missouri, United States	Withdrawn
Local Institution - 0024	Durham, North Carolina, United States	Withdrawn
Local Institution - 0025	Cincinnati, Ohio, United States	Withdrawn

+ 26 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04877288